Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.G&H Brands, a developer of over-the-counter topical treatment for premature ejaculation Promescent, has re-branded to Absorption Pharmaceuticals.
Subscribe to our email newsletter
The new name aligns with the company’s core technology – transdermal absorption of pharmaceutical agents.
Promescent, which employs a proprietary, eutectic mixture of lidocaine and other compounds, delivers controllable quantity of anesthetic to the penis and delays ejaculation.
The treatment is in compliance with the FDA monograph, ‘External Analgesic Drug Products for OTC Human Use’ under the OTC monograph 21 CFR Part 348.